ALR Technologies SG (ALRTF) Debt to Equity (2021 - 2025)

ALR Technologies SG posted quarterly Debt to Equity of -$0.58 for Q4 2025, down 219.35% year-on-year from $0.49 in Q4 2024, and up 8.02% on a QoQ basis from -$0.63 in Q2 2025.

ALR Technologies SG (ALRTF) has 4 years of Debt to Equity data on file, last reported at -$0.58 in Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 219.35% year-over-year to -$0.58; the trailing twelve-month figure through Dec 2025 stood at -$0.58 (down 219.35% YoY), and the FY2025 full-year result was -$0.58, down 219.35% from the prior year.
  • Debt to Equity for Q4 2025 stood at -$0.58, up from -$0.63 in the prior quarter.
  • Across five years, Debt to Equity topped out at -$0.18 in Q4 2024 and bottomed at -$0.66 in Q4 2023.
  • The 4-year median for Debt to Equity is -$0.61 (2025), against an average of -$0.55.
  • The widest annual swing landed in 2024, when Debt to Equity soared 72.37%; it then slumped 219.35% in 2025.
  • A 4-year view of Debt to Equity shows it stood at -$0.58 in 2021, then declined by 14.45% to -$0.66 in 2023, then surged by 72.37% to -$0.18 in 2024, then plunged by 219.35% to -$0.58 in 2025.
  • The last three Debt to Equity figures came in at -$0.58 (Q4 2025), -$0.63 (Q2 2025), and -$0.18 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 ALR Technologies SG - - - -0.58

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.58
Jun 30, 2025 -0.63
Dec 31, 2024 -0.18
Jun 30, 2024 -0.65
Dec 31, 2023 -0.66
Dec 31, 2021 -0.58